Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

<< Previous
Bullboard Posts
Next >>
Post by august202013on Oct 18, 2023 7:50am
230 Views
Post# 35688548

SCROLL BACK MIR ANNOUNCEMENT FOR 3RD QTR WAS ON 29-6-2023 &

SCROLL BACK MIR ANNOUNCEMENT FOR 3RD QTR WAS ON 29-6-2023 & PLEASE SCROLL BACK MIR 3RD QUARTERLY FINANCIAL RESULT ENDING 30-04-2023
WAS MADE ON 29-06-2023 IE WITHIN 60 DAYS NOT 90 OR 120 DAYS. AGAIN FOR 2ND QUARTERLY FINANCIAL RESULT ENDING 31-1-2023 WAS MADE ON 3-4-2023 AGAIN WITHIN 60 DAYS NOT 90 OR 120 DAYS,

HOPE MM-MIR WHO HAS ALREADY GOT THE YEAR ENDING FINANCIAL WANT TO SUPRISE MIR SHAREHOLDERS TO SYNCHRONISE IT WITH SOME OTHER NEWS INCLUDING IMPENDING OF HC.

IF SUPRISE IS IN STORE THEN ALL GOOD AND LONG TIME WAITING AND OVERDUE.

NO OTHERWISE ? NO OTHERWISE !
<< Previous
Bullboard Posts
Next >>